US · artificial_intelligence · marketing_technology · pharmaceutical
One round we have observed, with the investors the report named. Every figure below came from a named source, and where the company reported the raise to the SEC itself, that is shown beside it.
Series A · May 2026 · $21M
Transformation Capital lead, Twelve Below, Virtue Ventures
Reported by Ventureburn · SEC filing: $121M sold under the offering, first sale Feb 2026
Missing a round, or an investor who was in one? Tell us.